RAIT Financial Trust logo

RFTA - RAIT Financial Trust News Story

$20.9 0.0  0.0%

Sector
Financials
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6395

BUZZ-U.S. STOCKS ON THE MOVE-Progenics, AbbVie, Nike, Akebia

Fri 23rd March, 2018 12:46pm
* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh


    
U.S. stock index futures were lower on Friday, continuing a sell-off on Wall
Street a day earlier due to the rising threat of a global trade war after
President Donald Trump moved to impose tariffs on up to $60 billion of Chinese
goods.  .N 
    At 8:27 ET, Dow e-minis  1YMc1  were up 0.09 percent at 23,985. S&P 500
e-minis  ESc1  were up 0.17 percent at 2,647.75, while Nasdaq 100 e-minis  NQc1 
were down 0.10 percent at 6,685.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Alliance One International Inc  AOI.N , up 17.8 pct
 ** At Home Group Inc  HOME.N , up 10.7 pct
 ** Rait Financial Trust  RAS.N , up 9.5 pct
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** PPDAI Group  PPDF.N , down 5.9 pct
 ** Citizens Financial Group Inc  CFG.N , down 5.3 pct
 ** Switch Inc  SWCH.N , down 4.9 pct
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Top Ships Inc  TOPS.O , up 46.3 pct  urn:newsml:reuters.com:*:nL3N1R54BD
 ** RMG Networks Holding Corp  RMGN.O , up 17.9 pct
 ** Medigus Ltd  MDGS.O , up 16.9 pct
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Progenics Pharmaceuticals Inc  PGNX.O , down 15.1 pct  urn:newsml:reuters.com:*:nL3N1R544N
 ** Resonant Inc  RESN.O , down 11.4 pct
 ** Akebia Therapeutics Inc  AKBA.O , down 11.0 pct  urn:newsml:reuters.com:*:nL3N1R542O
 
 
 ** Nike Inc  NKE.N : up 4.9 pct premarket
 BUZZ-Street View: Nike Inc laced up a little tighter on Q3 beat  urn:newsml:reuters.com:*:nL3N1R52R5
 
** Progenics Pharma  PGNX.O : down 15.1 pct premarket
 BUZZ-Progenics Pharma: FDA extends review date of cancer drug  urn:newsml:reuters.com:*:nL3N1R45ZG
 BUZZ-Progenics Pharma: FDA delays drug review but analysts remain upbeat
 urn:newsml:reuters.com:*:nL3N1R544N
 
 ** Pfizer  PFE.N : down 0.8 pct premarket
 ** GlaxoSmithKline PLC  GSK.N : up 5.0 pct premarket
 BUZZ-GlaxoSmithKline: pulls out of $20 bln race for Pfizer assets  urn:newsml:reuters.com:*:nL8N1R51KR
 
 ** Dropbox Inc  DBX.O : market debut awaited 
 BUZZ-Dropbox: Braves tech wreck  urn:newsml:reuters.com:*:nL3N1R53Z5
 
 ** Pacific Biosciences  PACB.O : up 10.3 pct premarket
 BUZZ- Pacific Biosciences of California: Court denies motion to dismiss in
patent case  urn:newsml:reuters.com:*:nL3N1R53VI
 
 ** Resonant Inc  RESN.O : down 11.1 pct premarket
 BUZZ-Resonant: Falls after pricing of stock deal  urn:newsml:reuters.com:*:nL3N1R53ZD
 
 ** Micron Technology Inc  MU.O : down 1.7 pct premarket
 BUZZ-Micron: Citi downgrades high-flying stock on NAND pricing woes
 urn:newsml:reuters.com:*:nL3N1R5493
 
 ** Paycom Software Inc  PAYC.N : down 2.2 pct premarket
 BUZZ-Paycom: 5-star analyst downgrades to 'hold' on valuation  urn:newsml:reuters.com:*:nL3N1R54B8
 
 ** Akebia Therapeutics  AKBA.O : down 11.0 pct premarket
 BUZZ-Akebia Therapeutics: Down on planned stock offering  urn:newsml:reuters.com:*:nL3N1R542O
 
 ** Omeros Corp  OMER.O : down 1.9 pct premarket
 BUZZ-Omeros: Wedbush downgrades to 'neutral', does not see financial clarity
 urn:newsml:reuters.com:*:nL3N1R54CG
 
 ** Top Ships  TOPS.O : up 46.3 pct premarket
 BUZZ-Top Ships: Surges on reverse stock split  urn:newsml:reuters.com:*:nL3N1R54BD
 
 ** AbbVie Inc  ABBV.N : up 0.7 pct premarket
 BUZZ-Street View: AbbVie wounded by Rova-T trial but in race for long run
 urn:newsml:reuters.com:*:nL3N1R54H7

 (Compiled by Akshara P in Bengaluru)
 ((Reuters Messaging: akshara.p.thomsonreuters.com@reuters.net))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.